ImmuCell Suspends Mast Out(R) Partnering Effort; Pursuit of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
ImmuCell Suspends Mast Out(R) Partnering Effort; Pursuit of FDA Product Approval to Continue

PORTLAND, ME--(Marketwired - Jul 18, 2013) -   ImmuCell Corporation ( NASDAQ : ICCC ) today announced that it has suspended its active pursuit of a partner for Mast Out ® , its Nisin-based intramammary mastitis treatment product under development for dairy cows. 

ImmuCell has presented this product opportunity to a variety of large and small animal health companies. During the second quarter of 2013, ImmuCell received a $250,000 exclusive option payment from one prospective partner who decided not to execute a license after its final due diligence, which was conducted during the option period. This revenue will be recognized during the third quarter of 2013. Approximately $50,000 in related capitalized expenses will be written off during the third quarter of 2013.

ImmuCell was informed by the prospective partner that it "...could not cost effectively commercialize the product." During the protracted due diligence and negotiation process (which lasted more than 18 months), ImmuCell continued to move toward approval by the Center for Veterinary Medicine, U.S. Food and Drug Administration (FDA), gaining acceptance of the Effectiveness and Target Animal Safety Technical Sections. FDA acceptance of the Chemistry, Manufacturing and Controls Technical Section represents the rate limiting step to final marketing approval. 

"We are encouraged by the feedback from all prospective partners that our novel mastitis treatment can achieve FDA approval and have a significant, positive impact on the dairy industry," commented Michael F. Brigham, President and CEO. "Having been unable to establish terms which we consider to be fair and reasonable to both parties, we have decided to complete the final stages of the FDA approval process on our own in order to realize the optimal value for our stockholders." 

Commercial sales of Mast Out ® cannot begin until the New Animal Drug Application (NADA) is approved by the FDA. Previously, the FDA confirmed that the regulatory requirements to demonstrate effectiveness and safety had been met, as well as taking the unprecedented step of granting Mast Out ® both zero milk discard and zero meat withhold claims. This novel regulatory clearance creates a significant economic benefit to dairy producers by allowing them to sell milk while a cow is being treated. No other intramammary mastitis treatment can claim this "no-discard" status. 

ImmuCell's plan is to re-focus its efforts on obtaining NADA approval of Mast Out ® . Brigham further commented, "While recognizing the commercial and near-term financial advantages which could have been realized via a partnering agreement, the greatest long-term value for ImmuCell stockholders could be achieved through a more independent strategy at this stage. We remain confident that making this novel treatment option available to dairy producers in order to reduce their reliance on penicillin and cephalosporin-based products for the treatment of disease in dairy cattle is in the public interest, and we intend to take all appropriate steps to assure a successful commercialization of Mast Out ® ." 

About ImmuCell: ImmuCell Corporation's ( NASDAQ : ICCC ) purpose is to create scientifically-proven and practical products that result in a measurable economic impact on animal health and productivity in the dairy and beef industries. Press releases and other information about the Company are available at our web-site, ( http://www.immucell.com ).

Forward-Looking Statement Disclaimer The foregoing press release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Factors that could cause the Company's future results to differ materially from those described in the forward-looking statements, together with other risk factors, are detailed from time to time in filings made with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Forward-looking statements are based on our current information and expectations. Actual results may differ materially due to various factors, including those risks.

Contact: Michael F. Brigham President and CEO (207) 878-2770 Ext. 3106

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 181

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Cargo Drones to Skyrocket with $9.14B Value by 2031

Updated Category News Views 0

Riding the Drone Wave I tell you what, folks, the whole business of cargo drones is getting frickin' interesting. These flying gizmos, once dismissed as science fiction, are now barging their way into logistics discussions like an uninvited guest who's too worthwhile to ignore. MarketsandMarkets™ reckons this market's about to smash through the $9 billion ceiling by...

Continue Reading
Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 34

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 207

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 297

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Dar Global Expands Jeddah Portfolio with $267M Project

Updated Category News Views 0

Dar Global's Big Jeddah Move: A $267M Bet Alright, let's dive into what Dar Global's been up to in Saudi Arabia. They've just announced a whopping SAR 1 billion development project in Jeddah, bringing an international luxury brand to the city with an exclusive co-branded residential concept. Now that's something to chew on for any investor eyeing the Middle East's real...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 86

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 129

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 292

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

Carota Unveils Innovative MaaS Service to Transform Mobility

Updated Category News Views 248

Carota Announces Launch of Transformative MaaS Service In a significant move for the transportation sector, Carota has introduced its innovative MaaS (Mobility as a Service) smart mobility service. This decision comes as a response to the rapid changes in global mobility services, highlighting Carota's commitment to adapting and evolving to meet the needs of the modern...

Continue Reading
Fossil Group Sees Growth with Strong Q2 2025 Financials

Updated Category News Views 185

Fossil Group's Financial Performance in Q2 2025 Fossil Group, Inc. (NASDAQ: FOSL) has announced its financial results for the second quarter of 2025, showcasing significant progress amid a fluctuating market landscape. The company recorded worldwide net sales of $220 million, marking a year-over-year decline, yet also presenting an encouraging operating income. Sales...

Continue Reading
Exciting UPCX Global Staking Opportunity with Major Rewards

Updated Category News Views 141

UPCX Limited-Time Staking Event Unveiled UPCX, an innovative blockchain financial services platform, proudly announces an engaging staking opportunity that is designed to foster user participation and spur innovation within its ecosystem. This exciting event invites users to take part in a limited-time stakes initiative, offering a significant reward pool of 4,900 UPC,...

Continue Reading
PepGen Inc. Shareholder Alert: Lawsuit Update and Key Details

Updated Category News Views 187

Update on the PepGen Inc. Class Action Lawsuit Levi & Korsinsky, LLP has taken significant steps to notify investors in PepGen Inc. of a class action securities lawsuit aimed at protecting shareholders' interests. Investors should be aware that the lawsuit concerns allegations of securities fraud that impacted investors during a defined time frame. Understanding the Class...

Continue Reading
Synchronoss Technologies Engages Investors via Upcoming Events

Updated Category News Views 116

Synchronoss Technologies Engages Investors with Upcoming Conferences Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a renowned leader in Personal Cloud platforms, is set to make a significant impact at two investor conferences. The company's President and CEO, Jeff Miller, along with CFO, Louis Ferraro, are ready to share insights...

Continue Reading